Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii.
Natalia BagińskaAnna PichlakAndrzej GórskiEwa Jończyk-MatysiakPublished in: Virologica Sinica (2019)
Acinetobacter baumannii causes serious infections especially in immunocompromised and/or hospitalized patients. Several A. baumannii strains are multidrug resistant and infect wounds, bones, and the respiratory tract. Current studies are focused on finding new effective agents against A. baumannii. Phage therapy is a promising means to fight this bacterium and many studies on procuring and applying new phages against A. baumannii are currently being conducted. As shown in animal models, phages against multidrug-resistant A. baumannii may control bacterial infections caused by this pathogen and may be a real hope to solve this dangerous health problem.
Keyphrases
- multidrug resistant
- acinetobacter baumannii
- drug resistant
- respiratory tract
- gram negative
- klebsiella pneumoniae
- pseudomonas aeruginosa
- public health
- case control
- healthcare
- escherichia coli
- mental health
- stem cells
- health information
- bone marrow
- risk assessment
- climate change
- intensive care unit
- mesenchymal stem cells
- human health
- cell therapy
- wound healing
- extracorporeal membrane oxygenation
- respiratory failure
- mechanical ventilation